Peer-reviewedCC BY 4.0JAMA Network Open
The Keys to Opening Access to Clinical Trials
- 1Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee
Related
- Trials, tribulations, and formulations in access to new TB drugs for children: learning from rifapentine
- Association Between Postoperative Mechanical Alignment and Clinical Outcomes After Medial Opening-Wedge High Tibial Osteotomy: A Retrospective Cohort Study
- Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
- Therapies for Alcohol Use Disorder in Alcohol-associated Hepatitis Clinical Trials: Integrated Trial Design with a Composite Clinical Outcome as the Primary Endpoint
- Engaging Employees and Employers to Better Manage Employment Risk in Clinical Trials
BibTeX
@article{osarogiagbon2026keys,
title = {{The Keys to Opening Access to Clinical Trials}},
author = {Raymond U. Osarogiagbon},
journal = {JAMA Network Open},
year = {2026},
month = oct,
doi = {10.1001/jamanetworkopen.2026.32907},
url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854881},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Keys to Opening Access to Clinical Trials
AU - Raymond U. Osarogiagbon
PY - 2026
DA - 2026/10/06
JO - JAMA Network Open
DO - 10.1001/jamanetworkopen.2026.32907
UR - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854881
SN - 2574-3805
ER -